Cancer as a New Risk Factor for Major Adverse Cardiovascular Events in Secondary Prevention

被引：0
|
作者：
Melchiori, Renzo
Saravia, Sara Diaz
Szlaien, Lucas
Rubio, Pablo
Baratta, Sergio
Hita, Alejandro
Mourino, Romina
Rizzo, Manglio M.
机构：
来源：
CIRCULATION | 2023年 / 148卷
关键词：
Cardio-oncology; Acute coronary syndromes; Interventional cardiology; Cardiovascular disease;
D O I：
10.1161/circ.148.suppl_1.16592
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A16592
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Prediabetes as a risk factor for major adverse cardiovascular events
    Mando, Ramy
    Waheed, Muhammad
    Michel, Adrian
    Karabon, Patrick
    Halalau, Alexandra
    ANNALS OF MEDICINE, 2021, 53 (01) : 2090 - 2098
  • [2] ERECTILE DYSFUNCTION IS AN INDEPENDENT RISK FACTOR FOR MAJOR ADVERSE CARDIOVASCULAR EVENTS
    Mann, Uday
    Brar, Ranveer
    Patel, Premal
    JOURNAL OF UROLOGY, 2022, 207 (05): : E832 - E832
  • [3] ERECTILE DYSFUNCTION IS AN INDEPENDENT RISK FACTOR FOR MAJOR ADVERSE CARDIOVASCULAR EVENTS
    Mann, U.
    Brar, R.
    Patel, P.
    JOURNAL OF SEXUAL MEDICINE, 2023, 20
  • [4] Usefulness of Statins as Secondary Prevention Against Recurrent and Terminal Major Adverse Cardiovascular Events
    Tecson, Kristen M.
    Kluger, Aaron Y.
    Cassidy-Bushrow, Andrea E.
    Liu, Bin
    Coleman, Chad M.
    Jones, Laney K.
    Jefferson, Celeena R.
    VanWormer, Jeffrey J.
    McCullough, Peter A.
    AMERICAN JOURNAL OF CARDIOLOGY, 2022, 176 : 37 - 42
  • [5] Usefulness of Statins as Secondary Prevention Against Recurrent and Terminal Major Adverse Cardiovascular Events
    Tecson, Kristen M.
    Kluger, Aaron Y.
    Cassidy-Bushrow, Andrea E.
    Liu, Bin
    Coleman, Chad M.
    Jones, Laney K.
    Jefferson, Celeena R.
    VanWormer, Jeffrey J.
    McCullough, Peter A.
    AMERICAN JOURNAL OF CARDIOLOGY, 2022, 176 : 37 - 42
  • [6] Secondary prevention of major adverse cardiovascular events in patients with platelet membrane glycoprotein VI polymorphism
    Motovska, Z.
    Widimsky, P.
    Kocianova, I.
    Petr, R.
    Odvodyova, D.
    Fischerova, M.
    Katina, S.
    EUROPEAN HEART JOURNAL, 2010, 31 : 381 - 381
  • [7] Risk of Thromboembolic Events and Major Adverse Cardiovascular Events Following Antivascular Endothelial Growth Factor Therapy in Patients with Colorectal Cancer
    Chen, Yen-Cheng
    Yeh, Liang-Tsai
    Yang, Shun-Fa
    Chou, Ming-Chih
    Huang, Jing-Yang
    Yeh, Chao-Bin
    CANCERS, 2023, 15 (01)
  • [8] Predicting major adverse cardiovascular events for secondary prevention: protocol for a systematic review and meta-analysis of risk prediction models
    Akyea, Ralph K.
    Leonardi-Bee, Jo
    Asselbergs, Folkert W.
    Patel, Riyaz S.
    Durrington, Paul
    Wierzbicki, Anthony S.
    Ibiwoye, Oluwaseun H.
    Kai, Joe
    Qureshi, Nadeem
    Weng, Stephen F.
    BMJ OPEN, 2020, 10 (07):
  • [9] Liraglutide for the prevention of major adverse cardiovascular events in diabetic patients
    Madsbad, Sten
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2019, 17 (05) : 377 - 387
  • [10] JAK inhibitors: risk of major adverse cardiovascular events
    Reactions Weekly, 2025, 2052 (1) : 8 - 8
12345